Innovate, evaluate, expand
Australia is at the forefront of producing and trialling cutting-edge therapeutics. The industry is backed by a robust regulatory framework and bench to bedside innovation ecosystem, allowing businesses to do it all in Australia.
Summary
Australia is at the forefront of producing and trialling cutting-edge therapeutics. The industry is backed by a robust regulatory framework and bench to bedside innovation ecosystem, allowing businesses to do it all in Australia.
Benefits
The Australian life science industry has developed a critical mass over the past decade. It has grown by 40% since 2021 and has a market capitalisation of A$250 billion.
Benefits of doing business in Australia's life science sector include:
- exceptional health and medical research expertise
- bench-to-bedside innovation ecosystem
- world-class clinical trial capabilities
- government support including tax incentives
- reputation for quality data, robust regulation and intellectual property protection
- proximity and strong business links to the Asia Pacific.